The Bakersfield Californian

Kymera Therapeutics Announces Gilead Sciences’ Option Exercise to License KT-200, Oral ...

KT-200 is a first-in-class, oral CDK2 molecular glue degrader development candidate ...
AARP

Easy Ways for Caregivers to Motivate Sedentary Adults to Move More

Stay confident in today’s economy with useful tips and enter our $26K Sweepstakes! Help Register Login Login Hi, %{firstName} ...